Jaguar Health (JAGX) Current Assets (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Current Assets of $20.2 million for Q1 2026, down 33.6% year-over-year from $30.4 million in Q1 2025, and down 0.66% quarter-over-quarter from $20.3 million in Q4 2025.
Jaguar Health (JAGX) Current Assets (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Current Assets for 13 consecutive years, with $20.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 33.6% year-over-year to $20.2 million; the TTM figure through Mar 2026 stood at $20.2 million (down 33.6% YoY), while the FY2025 annual figure was $20.3 million, down 36.81% from the prior year.
- Current Assets retreated to $20.2 million in Q1 2026 per JAGX's latest filing, from $20.3 million in the prior quarter.
- Across five years, Current Assets topped out at $40.1 million in Q2 2024 and bottomed at $20.2 million in Q1 2026.
- Historically, Current Assets has averaged $28.3 million across 5 years, with a median of $28.2 million in 2023.
- Annual changes were most pronounced in 2022 — Current Assets slumped 47.26% — and 2024, when it surged 66.11%.
- Jaguar Health's Current Assets stood at $22.3 million in 2022, then rose by 25.28% to $28.0 million in 2023, then gained by 15.15% to $32.2 million in 2024, then slumped by 36.81% to $20.3 million in 2025, then fell by 0.66% to $20.2 million in 2026.
- Business Quant data shows JAGX's Current Assets at $20.2 million in Q1 2026, $20.3 million in Q4 2025, and $29.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 1.76 Bn |
| 10 | Jaguar Health | 438,522.96 | -9.63 Mn | 19.11 Mn | 20.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.21 Mn |
| Dec 31, 2025 | 20.35 Mn |
| Sep 30, 2025 | 29.40 Mn |
| Jun 30, 2025 | 27.90 Mn |
| Mar 31, 2025 | 30.44 Mn |
| Dec 31, 2024 | 32.20 Mn |
| Sep 30, 2024 | 36.64 Mn |
| Jun 30, 2024 | 40.11 Mn |
| Mar 31, 2024 | 33.71 Mn |
| Dec 31, 2023 | 27.96 Mn |
| Sep 30, 2023 | 22.06 Mn |
| Jun 30, 2023 | 28.23 Mn |
| Mar 31, 2023 | 32.36 Mn |
| Dec 31, 2022 | 22.32 Mn |
| Sep 30, 2022 | 25.21 Mn |
| Jun 30, 2022 | 23.36 Mn |
| Mar 31, 2022 | 28.47 Mn |
| Dec 31, 2021 | 28.43 Mn |
| Sep 30, 2021 | 24.01 Mn |
| Jun 30, 2021 | 44.29 Mn |